Azithromycin as part of COVID-19 management and mortality reduction: a systematic review of randomized controlled trials

Author

Jullianne Marie C. Bayoneto
Kwibuka Serge Bizaba
Ma. Lourdes Angela V. Briguela
Eliza Crisette C. Claudio
Czarina B. Gutay
Tomoyoshi Drake G. Hayase
Min Jung Kim
Ellaine Kate D. Olonan
Joshua Andrei D. Pandanan
Aries Raphael R. Pascua
Jinette Mary A. Surot
Ma. Rosel L. Trinidad

Date of Completion

2022

Document Type

Research Project

Degree Name

Clinical Pharmacology

Keywords

Azithromycin, COBID-19, Randomized Controlled Trial

First Advisor

Dr. Pearl Elizabeth Contemplacion

APA Citation

Bayoneto, J. M., Bizaba, K. S., Briguela, M. L. A., Claudio, E. C., Gutay, C., Hayase, T. D., Kim, M. J., Olonan, E. K., Pandanan, J. A., Pascua, A. R., Surot, J. M., & Trinidad, M. R. (2022). Azithromycin as part of COVID-19 management and mortality reduction: a systematic review of randomized controlled trials. [Research output, De La Salle Medical and Health Sciences Institute]. GreenPrints. https://greenprints.dlshsi.edu.ph/pharmacology/175/